In the present study, we examined the relationships between ratings on the Global Deterioration Scale (GDS) and activities of daily living and cognitive function in 39 individuals with vascular dementia (VaD). The results of the study revealed significant correlations between GDS rating and performance on cognitive tests, including memory and overall cognitive ability. In addition, the GDS was significantly related to ratings of instrumental activities of daily living. Comparisons between patients with VaD with GDS scores between 4 and 6 (n = 21) and patients with scores between 2 and 3 (n = 18) revealed greater cognitive and functional deficits in the group with higher GDS scores. Further, the GDS score accurately classified 87% of the patients with VaD. These findings provide support for the validity of the GDS in general staging of dementia severity of VaD. (J Geriatr Psychiatry Neurol 2002; 15:50-54).
Get full access to this article
View all access options for this article.
References
1.
Folstein MF, Folstein SE, McHugh PH.Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychosom Res1975; 12:189-198.
2.
Teng EL, Chui HC.The Modified Mini-Mental State (3MS) examination . J Clin Psychiatry1987; 48:314-318.
Salmon DP, Thal LJ, Butters N, Hemdel WC.Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations . Neurology1990; 40:1225-1230.
5.
Monsch AU, Bondi MW, Salmon DP, et al. Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Arch Neurol1995; 52:899-904.
6.
Suhr JA, Grace J.Brief cognitive screening of right hemisphere stroke: relation to functional outcome. Arch Phys Med Rehabil1999; 80:773-776.
7.
Tombaugh TN, McIntyre NJ.The Mini-Mental State Examination : a comprehensive review. J Am Geriatr Soc1992; 40:922-935.
8.
Reisberg B, Ferris SH, de Leon MJ, Crook T.The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry1982; 139:1136-1139.
9.
Winblad B, Poritis N.Memantine in severe dementia: results of the 9M-Best Study (benefit and efficacy in severely demented patients during treatment with memantine. Int J Geriatr Psychiatry1999; 14:135-146.
10.
Scharf S, Mander A, Ugoni A, et al. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. Neurology1999; 53:197-201.
11.
Moss DE, Berlanga P, Hagan MM, et al. Methanesulfonyl fluoride (MSF): a double-blind, placebo-controlled study of safety and efficacy in the treatment of senile dementia of the Alzheimer type. Alzheimer Dis Assoc Disord1999; 13:20-25.
12.
McDougall CJ.A review of screening instruments for assessing cognition and mental status in older adults. Nurs Pract1990; 15:18-28.
13.
Franssen EH, Reisberg B, Kluger A, et al. Cognition-independent neurologic symptoms in normal aging and probable Alzheimer's disease. Arch Neurol1991; 48:148-154.
14.
Dura JR, Haywood-Niler E, Kiecolt-Glaser JK.Spousal caregivers of persons with Alzheimer's and Parkinson's disease dementia: a preliminary comparison. Gerontologist1990 ; 30:332-336.
15.
Foster JR, Sclan S, Welkowitz J, et al. Psychiatric assessment in medical long term care facilities: reliability of commonly used rating scales. Int J Geriatr Psychiatry1988; 3:229-233.
16.
Gottlieb GL, Gur RE, Gur RC.Reliability of psychiatric scales in patients with dementia of the Alzheimer's type. Am J Psychiatry1988; 45:857-859.
17.
Hartmaier SL, Sloan PD, Guess HA, Koch GG.The MDS Cognition Scale: a valid instrument for identifying and staging nursing home residents with dementia using the minimum dataset. JAm Geriatr Soc1994; 42:1173-1179.
18.
Johansson B, Zarit SH.Dementia and cognitive impairment in the oldest old: a comparison of two rating methods. Int Psychogeriatr1991; 3:29-38.
19.
Overall JE, Scott J, Rhoades HM, Lesser J.Empirical scaling of the stages of cognitive decline in senile dementia. J Geriatr Psychiatry Neurol1990; 3:212-220.
Auer S, Reisberg B.The GDS/FAST staging system. Int Psychogeriatr1997; 9:167-171.
22.
Flicker C, Ferris SH, Reisberg B.Mild cognitive impairment in the elderly: predictors of dementia. Neurology1991; 41:1006-1009.
23.
Kluger A, Ferris SH, Golomb J, et al. Neuropsychological prediction of decline to dementia in nondemented elderly . J Geriatr Psychiatry Neurol1999 ; 12:168-179.
24.
Flicker C, Ferris SH, Reisberg B.A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease. J Geriatr Psychiatry Neurol1993 ; 6:84-96.
25.
Auer SR, Sclan SG, Yaffee RA, Reisberg B.The neglected half of Alzheimer's disease: cognitive and functional concomitants of severe dementia. JAm Geriatr Soc1994; 42:1266-1272.
26.
Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies . Neurology1993; 43:250-260.
27.
American Psychiatric Association.Diagnostic and statistical manual for mental disorders. 4th Ed. New York: APA, 1994.
28.
Delis D, Kramer J, Kaplan E, Obler B.Manual: California Verbal Learning Test, adult version. San Antonio, TX: The Psychological Corporation, 1987.
29.
Kaplan E, Goodglass H, Weintraub S.Boston Naming Test. Philadelphia: Lea and Febiger, 1983 .
30.
Lezak MD.Neuropsychological assessment. New York: Oxford University Press, 1995.
31.
Reitan RM.Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills1958; 8:271-276.
32.
Hooper HE.The Hooper Visual Organization Test. Los Angeles : Western Psychological Services, 1983.
33.
Wechsler D.Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation, 1981.
34.
Lawton MP, Brody EM.Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist1969; 9:179-186.
35.
Eisdorf C, Cohen D, Paveza CJ, et al. An empirical evaluation of the Global Deterioration Scale for staging Alzheimer's disease. Am J Psychiatry1992; 149:190-194.
